IBM Supplying Healthcare Providers with the Next Blockbuster Drug of the Century

Patient engagement has been called by leading analysts and healthcare professionals “the blockbuster drug of the century.” Why? Because studies have shown that patients actively engaged in their own healthcare have better health outcomes, while at the same time have lower overall health costs. In his August 2012 article, Leonard Kish references studies from Kaiser and the VA that showed significant improvements in health outcomes from engaged patients. Kish argues that had similar outcomes been achieved through the administration of a new drug, that drug would be hailed as the blockbuster drug of the century. Read More »